Cholesterol level increases greater with indinavir than saquinavir

被引:0
|
作者
机构
关键词
Cholesterol; Treatment Group; Protease Inhibitor; Cholesterol Level; Ritonavir;
D O I
10.2165/00128415-199907550-00004
中图分类号
学科分类号
摘要
引用
收藏
页码:3 / 3
相关论文
共 50 条
  • [1] Effect of coadministration of nelfinavir, indinavir, and saquinavir on the pharmacolkinetics of amprenavir
    Pfister, M
    Labbé, L
    Lu, JF
    Hammer, SM
    Mellors, J
    Bennett, KK
    Rosenkranz, S
    Sheiner, LB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (02) : 133 - 141
  • [2] Nephropathy and renal colic in patients treated with indinavir, ritonavir plus indinavir or ritonavir plus saquinavir
    Padberg, J
    Fritsche, L
    Bergmann, F
    Schürmann, D
    Suttorp, N
    AIDS, 1999, 13 (15) : 2173 - 2174
  • [3] A randomized clinical trial to compare the effectiveness of indinavir, ritonavir and saquinavir
    Teira, R
    Cámara, MM
    Escobar, A
    Muñoz, P
    de Munain, JL
    Santamaría, JM
    MEDICINA CLINICA, 2003, 121 (14): : 532 - 534
  • [5] Ritonavir-saquinavir rescue therapy in HIV-positive patients failing with indinavir, ritonavir or saquinavir
    De Wit, S
    Cassano, P
    Hermans, P
    Sommereijns, B
    Kabeya, K
    O'Doherty, E
    Clumeck, N
    AIDS, 1999, 13 (13) : 1794 - 1795
  • [6] Clinical pharmacology of HIV protease inhibitors: focus on saquinavir, indinavir, and ritonavir
    R.M.W. Hoetelmans
    C.H.W. Koks
    J.H. Beijnen
    P.L. Meenhorst
    J.W. Mulder
    D.M. Burger
    Pharmacy World and Science, 1997, 19 : 159 - 175
  • [7] Fenofibrate generates greater increases in HDL-cholesterol levels than atorvastatin in the treatment of obese and nonobese dyslipidemic patients
    Després, JP
    Delaval, D
    Salomon, H
    DIABETOLOGIA, 2001, 44 : A302 - A302
  • [8] Clinical pharmacology of HIV protease inhibitors: focus on saquinavir, indinavir, and ritonavir
    Hoetelmans, RMW
    Meenhorst, PL
    Mulder, JW
    Burger, DM
    Koks, CHW
    Beijnen, JH
    PHARMACY WORLD & SCIENCE, 1997, 19 (04): : 159 - 175
  • [9] Stroke patients have cholesterol level's greater than recommended by NCEP-ATP III guidelines
    不详
    FUTURE LIPIDOLOGY, 2007, 2 (02): : 124 - 124
  • [10] Synthesis and anti-HIV activity of prodrugs derived from saquinavir and indinavir
    Farèse-Di Giorgio, A
    Rouquayrol, M
    Greiner, J
    Aubertin, AM
    Vierling, P
    Guedj, R
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 2000, 11 (02): : 97 - 110